His research interest is in the pathogenesis and transmission of emerging viral pathogens, and the development of countermeasures against those pathogens. Heinz Feldmann was awarded with several honors including the ‘Löffler-Frosch Award’ from the German Society for Virology, the ‘Dalrymple/Young Award’ from the American Committee on Arthropod-Borne Viruses, and several Research Merit Awards from the Public Health Agency of Canada, the NIAID and the NIH. He is an elected member of the German Academy of Science (Leopoldina), the US National Academy of Medicine and the American Academy of Microbiology. His major scientific achievements of public health significance are the design and foundation of on-site laboratory support, the establishment of diverse animal disease models, and the development of treatments (e.g. antibodies, polymerase inhibitors) and vaccines (e.g. VSV-EBOV, Ervebo) for emerging/re-emerging viral pathogens.